Nuwellis Inc vs Schwab US Large Cap Growth ETF — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while Schwab US Large Cap Growth ETF trades at $34.25. The key difference: Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SCHG | |
|---|---|---|
Market Cap | $1.09M | — |
Sector | Technology | Sector/Thematic |
52-Week High | $527.46 | $35.30 |
52-Week Low | $2.80 | $28.10 |
Enterprise Value | -$722.58K | — |
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →